Medical School

  • University of the Witwatersrand , 1969 , Johannesburg , South Africa


  • Johannesburg Hospital , 1970 , Johannesburg , South Africa


  • Transvaal Memorial Hospital for Children , 1975 , Johannesburg , South Africa


  • University of Chicago Hospitals , 1976 , Chicago , IL


  • Tufts-New England Medical Center , 1978 , Boston , MA


  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Pediatric Endocrinology


Publications powered by Harvard Catalyst Profiles

  1. Transforming Education through a Global e-Learning Model for Pediatric Diabetes and Endocrinology. Horm Res Paediatr. 2021 Jun 30; 1-4. View abstract
  2. A global e-learning initiative for pediatric diabetes and endocrinology: Introduction and description. Pediatr Diabetes. 2021 Jun; 22(4):692-694. View abstract
  3. Post-Transplantation Diabetes Mellitus in Pediatric Patients. Horm Res Paediatr. 2020; 93(9-10):510-518. View abstract
  4. Precocious sexual development in a male toddler caused by unrecognized transdermal exposure to testosterone: case report and review of the literature. J Pediatr Endocrinol Metab. 2021 May 26; 34(5):675-678. View abstract
  5. Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom. J Clin Invest. 2021 Jan 04; 131(1). View abstract
  6. Brain injury in children with diabetic ketoacidosis: Review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema. Pediatr Diabetes. 2021 03; 22(2):148-160. View abstract
  7. Efficacy of GLP-1 Agonist Therapy in Autosomal Dominant WFS1-Related Disorder: A Case Report. Horm Res Paediatr. 2020; 93(6):409-414. View abstract
  8. ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes. 2020 12; 21(8):1394-1402. View abstract
  9. Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D). Pediatr Diabetes. 2020 08; 21(5):814-823. View abstract
  10. Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated Recommendations for Anesthesiologists. Anesth Analg. 2020 04; 130(4):821-827. View abstract
  11. Monitoring of Pediatric Type 1 Diabetes. Front Endocrinol (Lausanne). 2020; 11:128. View abstract
  12. Plasma ß-Hydroxybutyrate for the Diagnosis of Diabetic Ketoacidosis in the Emergency Department. Pediatr Emerg Care. 2020 Feb 01. View abstract
  13. International Society for Pediatric and Adolescent Diabetes in India: Reaching the unreached. Pediatr Diabetes. 2019 09; 20(6):665-667. View abstract
  14. SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution. Diabetes Care. 2019 Jun; 42(6):991-993. View abstract
  15. Incorporating dextrose gel and feeding in the treatment of neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed. 2020 Jan; 105(1):45-49. View abstract
  16. Glycogen storage disease presenting as Cushing syndrome. JIMD Rep. 2019 May; 47(1):17-22. View abstract
  17. Neither fluid rate nor sodium content affect neurocognitive outcomes in DKA. J Pediatr. 2019 03; 206:298-301. View abstract
  18. Hypoglycemia in the Newborn. Pediatr Clin North Am. 2019 04; 66(2):333-342. View abstract
  19. Pediatric Endocrinology Trainees' Education and Knowledge About Insulin Pumps and Continuous Glucose Monitors. Diabetes Technol Ther. 2019 03; 21(3):105-109. View abstract
  20. ISPAD Position Statement on Type 1 Diabetes in Schools. Pediatr Diabetes. 2018 11; 19(7):1338-1341. View abstract
  21. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018 10; 19 Suppl 27:155-177. View abstract
  22. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association. Diabetes Care. 2018 09; 41(9):2026-2044. View abstract
  23. Resolution of ketoacidosis in children with new onset diabetes: Evaluation of various definitions. Diabetes Res Clin Pract. 2018 Jan; 135:76-84. View abstract
  24. Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry. J Diabetes. 2016 Nov; 8(6):834-838. View abstract
  25. Utility of diabetes-associated autoantibodies for classification of new onset diabetes in children and adolescents. Pediatr Diabetes. 2016 09; 17(6):417-25. View abstract
  26. Use of Serum Bicarbonate to Substitute for Venous pH in New-Onset Diabetes. Pediatrics. 2015 Aug; 136(2):e371-7. View abstract
  27. The Impact of Technology on Current Diabetes Management. Pediatr Clin North Am. 2015 Aug; 62(4):873-88. View abstract
  28. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015 Aug; 167(2):238-45. View abstract
  29. Re-evaluating "transitional neonatal hypoglycemia": mechanism and implications for management. J Pediatr. 2015 Jun; 166(6):1520-5.e1. View abstract
  30. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014 Nov; 16(11):e1. View abstract
  31. ISPAD Clinical Practice Consensus Guidelines 2014. Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes. 2014 Sep; 15 Suppl 20:224-31. View abstract
  32. ISPAD Clinical Practice Consensus Guidelines 2014. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes. 2014 Sep; 15 Suppl 20:86-101. View abstract
  33. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014 Sep; 15 Suppl 20:154-79. View abstract
  34. The International Society of Pediatric and Adolescent Diabetes guidelines for management of diabetic ketoacidosis: Do the guidelines need to be modified? Pediatr Diabetes. 2014 Jun; 15(4):277-86. View abstract
  35. Routine behavioral and mental health screening in young children with type 1 diabetes mellitus. Pediatr Diabetes. 2014 Aug; 15(5):384-8. View abstract
  36. Health care transition in young adults with type 1 diabetes: barriers to timely establishment of adult diabetes care. Endocr Pract. 2013 Nov-Dec; 19(6):946-52. View abstract
  37. Transition experiences and health care utilization among young adults with type 1 diabetes. Patient Prefer Adherence. 2013; 7:761-9. View abstract
  38. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes. 2013 Sep; 14(6):447-54. View abstract
  39. Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism. J Clin Lipidol. 2012 Nov-Dec; 6(6):596-600. View abstract
  40. Health care transition in patients with type 1 diabetes: young adult experiences and relationship to glycemic control. Diabetes Care. 2012 Aug; 35(8):1716-22. View abstract
  41. Utility of immediate hemoglobin A1c in children with type I diabetes mellitus. Pediatr Diabetes. 2010 Nov; 11(7):450-4. View abstract
  42. Contemporary management of patients with type 1 diabetes. Endocrinol Metab Clin North Am. 2010 Sep; 39(3):573-93. View abstract
  43. Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. J Autoimmun. 2010 Jun; 34(4):408-15. View abstract
  44. Pediatrics: HbA1c levels for the diagnosis of diabetes mellitus in children. Nat Rev Endocrinol. 2010 Jun; 6(6):304-5. View abstract
  45. Research initiatives in neonatal hypoglycemia. J Pediatr. 2010 May; 156(5):862-3; author reply 863. View abstract
  46. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes. 2009 Sep; 10 Suppl 12:58-70. View abstract
  47. Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes. 2009 Sep; 10 Suppl 12:169-74. View abstract
  48. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes. 2009 Sep; 10 Suppl 12:118-33. View abstract
  49. How effective is continuous glucose monitoring in intensively treated type 1 diabetes mellitus? Nat Clin Pract Endocrinol Metab. 2009 Mar; 5(3):134-5. View abstract
  50. The delivery of ambulatory diabetes care: structures, processes, and outcomes of ambulatory diabetes care. Pediatr Diabetes. 2008 Dec; 9(6):609-20. View abstract
  51. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes. 2009 Apr; 10(2):97-104. View abstract
  52. Can biochemical markers discriminate between new-onset type 1 and type 2 diabetes mellitus in children? Nat Clin Pract Endocrinol Metab. 2007 Dec; 3(12):800-1. View abstract
  53. Management of children with diabetes requiring surgery. Pediatr Diabetes. 2007 Aug; 8(4):242-7. View abstract
  54. Diabetic ketoacidosis. Pediatr Diabetes. 2007 Feb; 8(1):28-43. View abstract
  55. Hypothyroidism in a breast-fed preterm infant resulting from maternal topical iodine exposure. J Pediatr. 2006 Oct; 149(4):566-7. View abstract
  56. How effective is biphasic insulin aspart in the treatment of adolescents with type 1 diabetes? Nat Clin Pract Endocrinol Metab. 2006 Sep; 2(9):486-7. View abstract
  57. Understanding protein-sensitive hypoglycemia. J Pediatr. 2006 Jul; 149(1):6-7. View abstract
  58. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care. 2006 May; 29(5):1150-9. View abstract
  59. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr. 2006 Mar; 148(3):366-71. View abstract
  60. Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia. Mol Genet Metab. 2006 Apr; 87(4):284-8. View abstract
  61. Children with diabetes benefit from exercise. Arch Dis Child. 2005 Dec; 90(12):1215-7. View abstract
  62. Perioperative management of pediatric surgical patients with diabetes mellitus. Anesth Analg. 2005 Oct; 101(4):986-99, table of contents. View abstract
  63. Effect of low-dose insulin treatment on body weight and physical development in children and adolescents at risk for type 1 diabetes. Diabetes Care. 2005 Aug; 28(8):1948-53. View abstract
  64. Diabetic ketoacidosis in children. Pediatr Clin North Am. 2005 Aug; 52(4):1147-63, ix. View abstract
  65. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. Diabetes Care. 2005 May; 28(5):1068-76. View abstract
  66. Diabetes mellitus in children and adolescents. Arch Med Res. 2005 May-Jun; 36(3):281-90. View abstract
  67. Sexual development in a 21 month-old boy caused by testosterone contamination of a topical hydrocortisone cream. J Pediatr Endocrinol Metab. 2005 May; 18(5):507-10. View abstract
  68. Perioperative management of diabetes insipidus in children. J Neurosurg Anesthesiol. 2004 Jul; 16(3):220-5. View abstract
  69. Oral sucrose and exercise tolerance in McArdle's disease. N Engl J Med. 2004 Apr 08; 350(15):1575-6; author reply 1575-6. View abstract
  70. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2004 Feb; 113(2):e133-40. View abstract
  71. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004 Feb; 89(2):188-94. View abstract
  72. Perioperative management of diabetes insipidus in children [corrected]. J Neurosurg Anesthesiol. 2004 Jan; 16(1):14-9. View abstract
  73. Glycogen storage diseases. Rev Endocr Metab Disord. 2003 Mar; 4(1):95-102. View abstract
  74. Bones benefit from better biochemical control in type 1 glycogen storage disease. J Pediatr. 2002 Sep; 141(3):308-10. View abstract
  75. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr. 2002 Oct; 161 Suppl 1:S35-9. View abstract
  76. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002 Nov 15; 100(10):3776-81. View abstract
  77. Leptin-replacement therapy in lipodystrophy. N Engl J Med. 2002 Jun 20; 346(25):2008-9; author reply 2009-10. View abstract
  78. Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations. J Pediatr. 2002 Jun; 140(6):781-3. View abstract
  79. Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr. 2001 Mar; 138(3):378-82. View abstract
  80. First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr. 2001 Feb; 138(2):244-9. View abstract
  81. Urinary lactate excretion to monitor the efficacy of treatment of type I glycogen storage disease. Mol Genet Metab. 2000 Jul; 70(3):189-95. View abstract
  82. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function. J Crit Care. 2000 Mar; 15(1):1-4. View abstract
  83. Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin North Am. 1999 Dec; 28(4):801-23. View abstract
  84. Improving diabetes control in adolescents. Diabetes Care. 1999 Nov; 22(11):1767-8. View abstract
  85. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease. J Pediatr Gastroenterol Nutr. 1999 Aug; 29(2):136-43. View abstract
  86. Hyperinsulinemic hypoglycemia of infancy. J Pediatr. 1998 Jan; 132(1):1-3. View abstract
  87. Fewer interventions in the immediate post-extubation management of pediatric intensive care unit patients: safety and cost containment. J Crit Care. 1997 Dec; 12(4):173-6. View abstract
  88. Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1997 Nov; 131(5):727-33. View abstract
  89. Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis. 1997 Aug; 20(4):559-68. View abstract
  90. Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr. 1997 May; 65(5):1507-11. View abstract
  91. Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care. 1997 May; 20(5):811-8. View abstract
  92. Social relationships among young adults with insulin-dependent diabetes mellitus: ten-year follow-up of an onset cohort. Diabet Med. 1997 Jan; 14(1):73-9. View abstract
  93. Psychosocial predictors of acute complications of diabetes in youth. Diabet Med. 1995 Jul; 12(7):612-8. View abstract
  94. Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med. 1994 Sep-Oct; 56(5):401-9. View abstract
  95. Diabetes in childhood: predicting the future. Pediatr Ann. 1994 Jun; 23(6):306-12. View abstract
  96. Glycogen storage disease in adults. Ann Intern Med. 1994 Feb 01; 120(3):218-26. View abstract
  97. Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease. J Inherit Metab Dis. 1994; 17(2):234-41. View abstract
  98. Distinction between transient hyperglycemia and early insulin-dependent diabetes mellitus in childhood: a prospective study of incidence and prognostic factors. J Pediatr. 1993 Sep; 123(3):347-54. View abstract
  99. Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease. Am J Clin Nutr. 1992 Sep; 56(3):587-92. View abstract
  100. Severe hypoglycemia in youth with insulin-dependent diabetes mellitus: frequency and causative factors. Pediatrics. 1991 Dec; 88(6):1187-93. View abstract
  101. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM. Diabetes Care. 1991 Nov; 14(11):1100-6. View abstract
  102. Clinic attendance and glycemic control. Study of contrasting groups of patients with IDDM. Diabetes Care. 1991 Jul; 14(7):599-601. View abstract
  103. Continuous glucose for treatment of patients with type 1 glycogen-storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables. Am J Clin Nutr. 1990 Dec; 52(6):1043-50. View abstract
  104. Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch. Am J Clin Nutr. 1990 Dec; 52(6):1051-7. View abstract
  105. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings. J Pediatr. 1990 Sep; 117(3):384-91. View abstract
  106. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: I. The influence of patient coping and adjustment. J Pediatr Psychol. 1990 Aug; 15(4):511-26. View abstract
  107. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: II. Immediate and long-term linkages with the family milieu. J Pediatr Psychol. 1990 Aug; 15(4):527-42. View abstract
  108. Screening for thyroid disease in children with IDDM. Diabetes Care. 1990 Jul; 13(7):801-3. View abstract
  109. Psychological characteristics of adults with IDDM. Comparison of patients in poor and good glycemic control. Diabetes Care. 1990 Apr; 13(4):375-81. View abstract
  110. Transient hyperglycemia in childhood: identification of a subgroup with imminent diabetes mellitus. Diabetes Res. 1988 Dec; 9(4):161-7. View abstract
  111. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care. 1988 Oct; 11(9):736-9. View abstract
  112. Relationship of nocturnal hypoglycemia to daytime glycemia in IDDM. Diabetes Care. 1988 Sep; 11(8):636-42. View abstract
  113. How families cope with diabetes in adolescence. An approach and case analyses. Pediatrician. 1988; 15(1-2):80-94. View abstract
  114. Psychologic predictors of compliance in children with recent onset of diabetes mellitus. J Pediatr. 1987 May; 110(5):805-11. View abstract
  115. Isolated growth hormone deficiency after cerebral edema complicating diabetic ketoacidosis. N Engl J Med. 1987 Apr 02; 316(14):857-9. View abstract
  116. Psychological adjustment of children with recently diagnosed diabetes mellitus. Diabetes Care. 1986 Jul-Aug; 9(4):323-9. View abstract
  117. Children with recently diagnosed diabetes: interactions within their families. Health Psychol. 1986; 5(3):273-96. View abstract
  118. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med. 1985 May 02; 312(18):1147-51. View abstract
  119. Ketonuria does not exclude hyperinsulinemic hypoglycemia. Am J Dis Child. 1984 Feb; 138(2):168-71. View abstract
  120. Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency. Metabolism. 1983 May; 32(5):457-62. View abstract
  121. Fat-derived fuels during a 24-hour fast in children. Eur J Pediatr. 1982 Mar; 138(2):141-4. View abstract
  122. Hypoalaninemia and ketotic hypoglycemia: cause or consequence? Eur J Pediatr. 1982 Feb; 138(1):28-31. View abstract
  123. Hyperprolactinemia causing primary amenorrhea. J Pediatr. 1981 Nov; 99(5):802-4. View abstract
  124. Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics. 1981 Sep; 68(3):405-6. View abstract
  125. Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1980 Aug; 51(2):345-53. View abstract
  126. Failure to thrive and metabolic alkalosis. Adverse effects of a chloride-deficient formula in two infants. JAMA. 1980 Mar 14; 243(10):1068-70. View abstract
  127. Hypoparathyroidism and pregnancy. Treatment with calcitriol. JAMA. 1980 Jan 18; 243(3):254-5. View abstract
  128. The diagnosis of insulinoma in a child in the absence of fasting hyperinsulinemia. Pediatrics. 1979 Oct; 64(4):496-8. View abstract
  129. Familial nesidioblastosis: severe neonatal hypoglycemia in two families. J Pediatr. 1979 Jul; 95(1):44-53. View abstract
  130. Hypoglycemia in children. Pediatr Clin North Am. 1979 Feb; 26(1):171-85. View abstract
  131. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh). 1978 Jun; 88(2):321-8. View abstract
  132. Kerosene absorption in primates. J Pediatr. 1977 Sep; 91(3):495-8. View abstract
  133. Hepatic enzymes, their induction and usefulness in predicting maximal serum bilirubin levels in premature newborn infants. Eur J Pediatr. 1977 Jun 01; 125(2):97-102. View abstract
  134. Growth and nutrition of uremic piglets. Pediatr Res. 1976 Nov; 10(11):937-44. View abstract
  135. Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. S Afr Med J. 1976 Jul 24; 50(32):1233-7. View abstract
  136. Kerosene intoxication: an experimental approach to the etiology of the CNS manifestations in primates. J Pediatr. 1976 Jun; 88(6):1037-40. View abstract
  137. Transpyloric feeding in small preterm infants. Arch Dis Child. 1975 Sep; 50(9):723-6. View abstract
  138. Bicarbonate excretion in kwashiorkor. S Afr Med J. 1975 Aug 09; 49(34):1398-400. View abstract
  139. Transcutaneous determination of arterial oxygen tension. Pediatrics. 1975 Feb; 55(2):224-31. View abstract
  140. The influence of body position on pulmonary function in low birthweight babies. S Afr Med J. 1975 Jan 18; 49(3):79-81. View abstract
  141. The acute care of respiratory problems in the neonate, infant, and child. Int Anesthesiol Clin. 1975; 13(3):73-131. View abstract
  142. Dexamethasone in the management of kerosene pneumonia. Pediatrics. 1974 Jan; 53(1):86-90. View abstract
  143. Report by the department of paediatrics on the special care area of the Transvaal Memorial Hospital for Children. S Afr Med J. 1973 Oct 13; 47(40):1851-4. View abstract
  144. Mist therapy reconsidered; an evaluation of the respiratory deposition of labelled water aerosols produced by jet and ultrasonic nebulizers. Pediatrics. 1969 May; 43(5):799-808. View abstract
  145. Mist therapy. Pediatrics. 1969 May; 43(5):903-4. View abstract
  146. Tuberculosis in children. Clin Notes Respir Dis. 1969; 7(4):3-10. View abstract
  147. Diagnosis and treatment: approaches to newborn infants of tuberculous mothers. Pediatrics. 1968 Sep; 42(3):519-22. View abstract
  148. Screening tests for growth-hormone deficiency in dwarfism. Lancet. 1967 Dec 16; 2(7529):1271-3. View abstract